Letter: Covid-19-re-initiating clinical services for chronic gastrointestinal diseases. How and when?

Aliment Pharmacol Ther. 2020 Oct;52(8):1414-1415. doi: 10.1111/apt.16061.

Abstract

LINKED CONTENT

This article is linked to Al‐Ani et al and Prentice et al papers. To view these articles, visit https://doi.org/10.1111/apt.15779 and https://doi.org/10.1111/apt.16065

Publication types

  • Letter
  • Comment

MeSH terms

  • Betacoronavirus
  • COVID-19
  • COVID-19 Testing
  • Clinical Laboratory Techniques
  • Coronavirus Infections* / diagnosis
  • Gastrointestinal Diseases* / drug therapy
  • Gastrointestinal Diseases* / epidemiology
  • Humans
  • Inflammatory Bowel Diseases* / epidemiology
  • Pandemics*
  • Pneumonia, Viral*
  • SARS-CoV-2